{{'Tue, 23 Mar 2021 14:17:00 -0400' | dateFormatUsFilter}}
Adults with obesity treated with semaglutide 2.4 mg achieved and maintained a significant amount of weight loss in a 68-week trial
Read more
{{'Mon, 15 Mar 2021 09:23:00 -0400' | dateFormatUsFilter}}
Data from STEP clinical trial program evaluating effect of semaglutide 2.4 mg in people with obesity to be presented at 2021 ENDO annual meeting
Read more
{{'Thu, 04 Mar 2021 14:15:00 -0500' | dateFormatUsFilter}}
Obesity is a disease: Understanding the science and working together to raise awareness
Read more
Here are our current job openings. If we don’t currently have an opening in your area of interest, we encourage you to create a job agent and candidate profile.